Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. September 2016 07:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics to Present at Upcoming Investor Conferences

RAMSEY, N.J., Sept. 01, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
12. August 2016 16:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Reports Second Quarter 2016 Results

RAMSEY, N.J., Aug. 12, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
29. Juli 2016 19:14 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application

RAMSEY, N.J., July 29, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty...
16. Juni 2016 07:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference

RAMSEY, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
13. Mai 2016 17:05 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Reports First Quarter 2016 Results

RAMSEY, N.J., May 13, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
13. Mai 2016 16:05 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Further Enhances Cash Position by Securing $4.0 Million in Additional Capital Through Amended Loan and Security Agreement with Oxford Finance

RAMSEY, N.J., May 13, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty...
03. Mai 2016 10:46 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

RAMSEY, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
28. April 2016 09:15 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Announces Pricing of Public Offering of Common Stock

RAMSEY, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
27. April 2016 16:05 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Announces Proposed Public Offering of Common Stock

RAMSEY, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
12. April 2016 07:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Announces Data on RI-002 to be Presented at the Clinical Immunology Society 2016 Annual Meeting

RAMSEY, N.J., April 12, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...

Vorherige Seite